ChronoScale Extends Microsoft AI Compute Partnership to Three Years
CHRN has more than doubled off its 52-week low of $3.47.
Summary
ChronoScale announced a 50 MW AI compute deployment with Microsoft featuring NVIDIA GB300 NVL72 systems, and extended the partnership term from two years to three years.
Key Events · M&A and Partnerships · CHRN
-
Microsoft Partnership Term Extended
ChronoScale and Microsoft agreed to extend their strategic partnership from two years to three years for the planned 50 MW AI compute deployment.
-
50 MW AI Compute Deployment
The deployment will feature NVIDIA GB300 NVL72 systems with advanced liquid-cooling infrastructure in North America, designed for high-density AI training and inference workloads.
-
NVIDIA Endorsement
NVIDIA VP Raj Mirpuri publicly endorsed the deployment, stating ChronoScale's GB300 NVL72 systems will provide the performance and efficiency developers need for frontier AI.
-
Financial Context
The extended partnership follows ChronoScale's first 10-K showing a $50.3M net loss and a $100M credit line from its parent, Applied Digital.
Analysis · CHRN · Technology
ChronoScale formalized its previously announced 50 MW AI compute deployment with Microsoft and extended the partnership term from two years to three years. The extension adds a year of contracted runway to a deal that pairs ChronoScale's infrastructure with NVIDIA GB300 NVL72 systems and liquid cooling. Against a backdrop of a $50.3M net loss and reliance on a $100M parent credit line, locking in a longer Microsoft relationship is a meaningful validation of the company's AI infrastructure strategy.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 32.3% of the 2077 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHRN was trading at $20.74 on NASDAQ in the Technology sector, with a market capitalization of approximately $3B. The 52-week trading range was $3.47 to $30.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.